UnitedHealth missed earnings estimates but kept 2025 guidance, stock holds "Hold" rating.

UnitedHealth Group reported second-quarter earnings of $4.08 per share, missing estimates, and revenue of $111.62 billion, slightly below expectations, though up 12.9% year-over-year. The company maintained its 2025 full-year earnings guidance at $16.00 per share, while analysts expect $29.54. The stock, trading at $354.30 with a market cap of $320.88 billion, has a consensus "Hold" rating and a target price of $383.09. Institutional investors own 87.86% of shares.